BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33059362)

  • 1. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.
    Casey R; Neumann HPH; Maher ER
    Hum Mol Genet; 2020 Oct; 29(R2):R128-R137. PubMed ID: 33059362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.
    Björklund P; Pacak K; Crona J
    J Intern Med; 2016 Dec; 280(6):559-573. PubMed ID: 27165774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma: When to search a germline defect?
    Buffet A; Burnichon N; Amar L; Gimenez-Roqueplo AP
    Presse Med; 2018; 47(7-8 Pt 2):e109-e118. PubMed ID: 30100270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
    Lima JV; Kater CE
    Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
    Taïeb D; Wanna GB; Ahmad M; Lussey-Lepoutre C; Perrier ND; Nölting S; Amar L; Timmers HJLM; Schwam ZG; Estrera AL; Lim M; Pollom EL; Vitzthum L; Bourdeau I; Casey RT; Castinetti F; Clifton-Bligh R; Corssmit EPM; de Krijger RR; Del Rivero J; Eisenhofer G; Ghayee HK; Gimenez-Roqueplo AP; Grossman A; Imperiale A; Jansen JC; Jha A; Kerstens MN; Kunst HPM; Liu JK; Maher ER; Marchioni D; Mercado-Asis LB; Mete O; Naruse M; Nilubol N; Pandit-Taskar N; Sebag F; Tanabe A; Widimsky J; Meuter L; Lenders JWM; Pacak K
    Lancet Diabetes Endocrinol; 2023 May; 11(5):345-361. PubMed ID: 37011647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
    Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
    Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
    Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
    J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
    Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
    Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
    van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
    Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International initiative for a curated
    Ben Aim L; Maher ER; Cascon A; Barlier A; Giraud S; Ercolino T; Pigny P; Clifton-Bligh RJ; Mirebeau-Prunier D; Mohamed A; Favier J; Gimenez-Roqueplo AP; Schiavi F; Toledo RA; Dahia PL; Robledo M; Bayley JP; Burnichon N
    J Med Genet; 2022 Aug; 59(8):785-792. PubMed ID: 34452955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    Lenders JWM; Kerstens MN; Amar L; Prejbisz A; Robledo M; Taieb D; Pacak K; Crona J; Zelinka T; Mannelli M; Deutschbein T; Timmers HJLM; Castinetti F; Dralle H; Widimský J; Gimenez-Roqueplo AP; Eisenhofer G
    J Hypertens; 2020 Aug; 38(8):1443-1456. PubMed ID: 32412940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic bases of pheochromocytoma and paraganglioma.
    Cascón A; Calsina B; Monteagudo M; Mellid S; Díaz-Talavera A; Currás-Freixes M; Robledo M
    J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36520714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.